HUP0200190A3 - Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing them - Google Patents
Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP0200190A3 HUP0200190A3 HU0200190A HUP0200190A HUP0200190A3 HU P0200190 A3 HUP0200190 A3 HU P0200190A3 HU 0200190 A HU0200190 A HU 0200190A HU P0200190 A HUP0200190 A HU P0200190A HU P0200190 A3 HUP0200190 A3 HU P0200190A3
- Authority
- HU
- Hungary
- Prior art keywords
- neuraminidase
- inhibitors
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 102000005348 Neuraminidase Human genes 0.000 title 1
- 108010006232 Neuraminidase Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/595—Polyamides, e.g. nylon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP9139A AUPP913999A0 (en) | 1999-03-12 | 1999-03-12 | Novel chemical compounds and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0200190A2 HUP0200190A2 (en) | 2002-06-29 |
HUP0200190A3 true HUP0200190A3 (en) | 2004-01-28 |
Family
ID=3813338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0200190A HUP0200190A3 (en) | 1999-03-12 | 2000-03-09 | Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing them |
Country Status (26)
Country | Link |
---|---|
US (1) | US6548476B1 (hu) |
EP (1) | EP1165541B1 (hu) |
JP (1) | JP5160000B2 (hu) |
KR (1) | KR100805906B1 (hu) |
CN (1) | CN1343205A (hu) |
AP (1) | AP2001002277A0 (hu) |
AT (1) | ATE295361T1 (hu) |
AU (2) | AUPP913999A0 (hu) |
BR (1) | BR0008939A (hu) |
CA (1) | CA2367755C (hu) |
CZ (1) | CZ20013274A3 (hu) |
DE (1) | DE60020100T2 (hu) |
EA (1) | EA200100968A1 (hu) |
ES (1) | ES2241581T3 (hu) |
HK (1) | HK1041693B (hu) |
HU (1) | HUP0200190A3 (hu) |
ID (1) | ID29868A (hu) |
IL (1) | IL145346A (hu) |
MX (1) | MXPA01009203A (hu) |
NO (1) | NO327812B1 (hu) |
NZ (1) | NZ514041A (hu) |
PL (1) | PL350228A1 (hu) |
TR (1) | TR200102794T2 (hu) |
TW (1) | TWI268279B (hu) |
WO (1) | WO2000055149A1 (hu) |
ZA (1) | ZA200107450B (hu) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9714299A (pt) * | 1996-11-14 | 2000-04-25 | Biota Scient Mangent Pty Ltd | Composto macromolecular, processos para detecção de virus da influenza e tratamento de infeção da influenza, composição farmacêutica para esse tratamento e utilização de composto |
DE19930177B4 (de) | 1999-06-30 | 2007-02-08 | Nikolai Vladimirovich Bovin | Intermolekular assoziierende Verbindungen und deren Verwendung |
AUPQ288499A0 (en) | 1999-09-16 | 1999-10-07 | Biota Scientific Management Pty Ltd | Antiviral agents |
AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AU2002340635B2 (en) * | 2001-11-09 | 2008-03-13 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
US7157494B2 (en) * | 2001-11-09 | 2007-01-02 | Biota Scientific Management Pty. Ltd. | Dimeric compounds and their use as anti-viral agents |
AUPR879701A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AUPR879501A0 (en) | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AUPR879601A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AU2002340632B2 (en) * | 2001-11-09 | 2008-03-20 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
AUPR879401A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AU2002336823B2 (en) * | 2001-11-09 | 2008-03-20 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
KR101857900B1 (ko) | 2002-09-06 | 2018-05-14 | 인설트 테라페틱스, 인코퍼레이티드 | 공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체 |
US7144450B2 (en) * | 2004-12-04 | 2006-12-05 | Xerox Corporation | Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds |
US7576235B2 (en) | 2004-12-04 | 2009-08-18 | Xerox Corporation | Processes for preparing bis(urea-urethane) compounds |
US7314949B2 (en) | 2004-12-04 | 2008-01-01 | Xerox Corporation | Trans-1,2-cyclohexane bis(urea-urethane) compounds |
US7317122B2 (en) | 2004-12-04 | 2008-01-08 | Xerox Corporation | Curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
US7220300B2 (en) | 2004-12-04 | 2007-05-22 | Xerox Corporation | Phase change inks containing bis(urea-urethane) compounds |
US7560587B2 (en) * | 2004-12-04 | 2009-07-14 | Xerox Corporation | Bis[urea-urethane] compounds |
US7153349B2 (en) | 2004-12-04 | 2006-12-26 | Xerox Corporation | Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
WO2008090151A1 (en) * | 2007-01-23 | 2008-07-31 | Therapicon Srl | Antiviral compounds |
US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
CA2690440A1 (en) | 2007-07-03 | 2009-01-08 | Children's Hospital & Research Center At Oakland | Oligosialic acid derivatives, methods of manufacture, and immunological uses |
WO2009006591A1 (en) | 2007-07-03 | 2009-01-08 | Children's Hospital & Research Center At Oakland | Inhibitors of polysialic acid de-n-acetylase and methods for using the same |
WO2009006613A1 (en) | 2007-07-03 | 2009-01-08 | Children's Hospital & Research Center At Oakland | Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
DK2318832T3 (da) | 2008-07-15 | 2014-01-20 | Academia Sinica | Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder |
MX366955B (es) * | 2009-09-15 | 2019-07-31 | Bluelink Pharmaceuticals Inc | Crlx101 para usarse en el tratamiento de cáncer. |
IT1396620B1 (it) * | 2009-11-25 | 2012-12-14 | Therapicon Srl | Analoghi chimerici |
US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
CN103180333A (zh) * | 2010-08-24 | 2013-06-26 | 英皇创新有限公司 | 聚丙基醚亚胺的糖树状聚体 |
CN104080450A (zh) * | 2012-01-05 | 2014-10-01 | 阿拉维制药公司 | 扎那米韦生物利用度增强的制剂 |
US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
EP2885311B1 (en) | 2012-08-18 | 2020-01-01 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
US20140094432A1 (en) | 2012-10-02 | 2014-04-03 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
US9981030B2 (en) | 2013-06-27 | 2018-05-29 | Academia Sinica | Glycan conjugates and use thereof |
EP3041484B1 (en) | 2013-09-06 | 2021-03-03 | Academia Sinica | Human inkt cell activation using glycolipids with altered glycosyl groups |
US10023892B2 (en) | 2014-05-27 | 2018-07-17 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
KR20160104727A (ko) | 2014-01-16 | 2016-09-05 | 아카데미아 시니카 | 암의 치료 및 검출을 위한 조성물 및 방법 |
JP6562942B2 (ja) | 2014-03-27 | 2019-08-28 | アカデミア シニカAcademia Sinica | 反応性標識化合物およびその使用 |
KR20170003720A (ko) | 2014-05-27 | 2017-01-09 | 아카데미아 시니카 | 항-cd20 글리코항체 및 이의 용도 |
US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
KR102512592B1 (ko) | 2014-05-27 | 2023-03-21 | 아카데미아 시니카 | 항-her2 글리코항체 및 이의 용도 |
US11332523B2 (en) | 2014-05-28 | 2022-05-17 | Academia Sinica | Anti-TNF-alpha glycoantibodies and uses thereof |
US9879042B2 (en) | 2014-09-08 | 2018-01-30 | Academia Sinica | Human iNKT cell activation using glycolipids |
US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
AU2015378564A1 (en) | 2015-01-24 | 2017-07-13 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
SG11201803962WA (en) * | 2015-11-20 | 2018-06-28 | Australian Biomedical Co Pty Ltd | Compounds for medicinal applications |
RU2612221C1 (ru) * | 2015-12-16 | 2017-03-03 | Общество с ограниченной ответственностью "Синтавр" | Блокаторы вируса гриппа |
EP3426693A4 (en) | 2016-03-08 | 2019-11-13 | Academia Sinica | PROCESS FOR MODULAR SYNTHESIS OF N-GLYCANES AND ARRANGEMENTS THEREOF |
TWI764917B (zh) | 2016-08-22 | 2022-05-21 | 醣基生醫股份有限公司 | 抗體、結合片段及使用方法 |
CN108003065B (zh) * | 2016-10-27 | 2021-01-08 | 中国石油化工股份有限公司 | 一种具有增稠作用的化合物和润滑脂以及它们的制备方法 |
WO2018199798A1 (ru) * | 2017-04-28 | 2018-11-01 | Общество с ограниченной ответственностью "Синтавр" | Пептидные производные противовирусного препарата занамивира |
EP3630740A4 (en) * | 2017-05-25 | 2021-03-31 | The Governors of the University of Alberta | METHODS FOR THE PREVENTION OR TREATMENT OF ATHEROSCLEROSIS WITH ISOENZYME INHIBITORS SPECIFIC TO HUMAN NEURAMINIDASE |
CN111698999A (zh) * | 2017-12-06 | 2020-09-22 | 阿道恰公司 | 包含至少一种pi在5.8与8.5之间的基础胰岛素和带有羧酸根电荷及疏水基的共聚氨基酸的ph为7的可注射溶液 |
EP3846846A4 (en) | 2018-09-06 | 2022-08-03 | Cidara Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRUS INFECTION |
SG11202102661UA (en) * | 2018-10-05 | 2021-04-29 | Univ Emory | Monomer and multimeric anti-hbv agents |
TW202122117A (zh) | 2019-09-06 | 2021-06-16 | 美商席達拉醫療有限公司 | 用於治療病毒感染之組合物及方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5243035A (en) * | 1990-02-27 | 1993-09-07 | Drug Delivery System Institute, Ltd. | Sialic acid-containing glycolipid derivatives |
DE69231127D1 (de) * | 1991-03-18 | 2000-07-06 | Scripps Research Inst La Jolla | Oligosaccharide als enzymsubstrate und -inhibitoren: verfahren und zusammensetzungen |
CA2129987A1 (en) * | 1992-02-19 | 1993-09-02 | Naoya Kojima | Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
JPH0638784A (ja) * | 1992-03-30 | 1994-02-15 | Meiji Milk Prod Co Ltd | シアル酸を構成要素とする糖鎖の製造方法 |
ZA937034B (en) * | 1992-09-24 | 1995-06-23 | Brigham & Womens Hospital | Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines |
US5837689A (en) * | 1993-06-16 | 1998-11-17 | Glycomed Incorporated | Sialyl lewis-x mimetics containing naphthyl backbones |
US5658880A (en) * | 1993-06-16 | 1997-08-19 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
ATE305453T1 (de) * | 1995-02-27 | 2005-10-15 | Gilead Sciences Inc | Selektive inhibitoren viraler oder bakterieller neuraminidase |
US5780606A (en) * | 1995-06-07 | 1998-07-14 | Connaught Laboratories Limited | Neisseria meningitidis capsular polysaccharide conjugates |
IL125662A0 (en) | 1996-03-01 | 1999-04-11 | Biota Scient Management | Method of detecting influenza virus and compounds for use therein |
US5891862A (en) * | 1996-03-15 | 1999-04-06 | Geltex Pharmaceuticals, Inc. | Polyvalent polymers for the treatment of rotavirus infection |
AUPO104396A0 (en) | 1996-07-17 | 1996-08-08 | Biomolecular Research Institute Limited | Antiviral linear polymers |
DE69739750D1 (de) * | 1996-07-23 | 2010-03-18 | Seikagaku Kogyo Co Ltd | Neue laktosamin-oligosaccharide und verfahren zu ihrer herstellung |
BR9714299A (pt) | 1996-11-14 | 2000-04-25 | Biota Scient Mangent Pty Ltd | Composto macromolecular, processos para detecção de virus da influenza e tratamento de infeção da influenza, composição farmacêutica para esse tratamento e utilização de composto |
JPH10182686A (ja) * | 1996-12-26 | 1998-07-07 | Ngk Insulators Ltd | ガングリオシドGQ1b類縁物質 |
JP3304985B2 (ja) | 1997-04-17 | 2002-07-22 | ジョンソン・エンド・ジョンソン株式会社 | ケミカルインジケーターシートおよびそれを使用した滅菌用包装袋 |
WO1999063929A2 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
-
1999
- 1999-03-12 AU AUPP9139A patent/AUPP913999A0/en not_active Abandoned
-
2000
- 2000-03-09 DE DE60020100T patent/DE60020100T2/de not_active Expired - Lifetime
- 2000-03-09 ES ES00907354T patent/ES2241581T3/es not_active Expired - Lifetime
- 2000-03-09 EP EP00907354A patent/EP1165541B1/en not_active Expired - Lifetime
- 2000-03-09 CN CN00804901A patent/CN1343205A/zh active Pending
- 2000-03-09 BR BR0008939-7A patent/BR0008939A/pt not_active IP Right Cessation
- 2000-03-09 TR TR2001/02794T patent/TR200102794T2/xx unknown
- 2000-03-09 PL PL00350228A patent/PL350228A1/xx unknown
- 2000-03-09 HU HU0200190A patent/HUP0200190A3/hu unknown
- 2000-03-09 CZ CZ20013274A patent/CZ20013274A3/cs unknown
- 2000-03-09 WO PCT/AU2000/000165 patent/WO2000055149A1/en active IP Right Grant
- 2000-03-09 JP JP2000605578A patent/JP5160000B2/ja not_active Expired - Fee Related
- 2000-03-09 EA EA200100968A patent/EA200100968A1/ru unknown
- 2000-03-09 NZ NZ514041A patent/NZ514041A/xx not_active Application Discontinuation
- 2000-03-09 CA CA002367755A patent/CA2367755C/en not_active Expired - Fee Related
- 2000-03-09 MX MXPA01009203A patent/MXPA01009203A/es active IP Right Grant
- 2000-03-09 AP APAP/P/2001/002277A patent/AP2001002277A0/en unknown
- 2000-03-09 KR KR1020017011546A patent/KR100805906B1/ko not_active IP Right Cessation
- 2000-03-09 ID IDW00200101979A patent/ID29868A/id unknown
- 2000-03-09 AT AT00907354T patent/ATE295361T1/de not_active IP Right Cessation
- 2000-03-09 AU AU28966/00A patent/AU774222B2/en not_active Ceased
- 2000-03-09 IL IL14534600A patent/IL145346A/xx not_active IP Right Cessation
- 2000-09-08 US US09/658,445 patent/US6548476B1/en not_active Expired - Lifetime
- 2000-09-08 TW TW089118492A patent/TWI268279B/zh not_active IP Right Cessation
-
2001
- 2001-09-10 ZA ZA200107450A patent/ZA200107450B/xx unknown
- 2001-09-11 NO NO20014409A patent/NO327812B1/no not_active IP Right Cessation
-
2002
- 2002-05-02 HK HK02103316.9A patent/HK1041693B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0200190A3 (en) | Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing them | |
HUP0200572A2 (en) | Amine derivatives as protease inhibitors process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0203669A3 (en) | Renin inhibitors, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0204226A3 (en) | Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds | |
HUP0300565A3 (en) | 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors, their use, process for their preparation and pharmaceutical compositions containing them | |
HUP0203453A3 (en) | Quinazoline derivatives as vegf inhibitors, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0203122A3 (en) | Fab i inhibitors, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0200881A2 (en) | Renin inhibitors, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
HUP0004120A3 (en) | Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy | |
HUP0302487A3 (en) | New mandelic acid derivatives and their use as throbin inhibitors, process for their preparation and pharmaceutical compositions containing them | |
HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
HUP0203136A3 (en) | Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0203548A3 (en) | New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0203257A3 (en) | Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them | |
HUP0203183A3 (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use | |
HUP0202186A3 (en) | Benzimidazolone derivatives, process for their preparation, pharmaceutical compositions containing them and their use as phosphodiesterase inhibitors for producing pharmaceutical compositions | |
HUP0105108A3 (en) | Amide compounds, process for their preparation and pharmaceutical compositions containing them | |
HUP0301683A3 (en) | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral indopeptidase, their intermediates, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
HUP0202075A3 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0203422A3 (en) | Imidazole derivatives as phosphodiesterase vii inhibitors, process for their preparation and pharmaceutical compositions containing them | |
HUP0204347A3 (en) | Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them and their use | |
HUP0200213A3 (en) | Alkynyl containing hydroxamic acid compounds as tace inhibitors, process for their preparation and pharmaceutical compositions containing them | |
HUP0201315A3 (en) | 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |